OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.

Will they re-sign veteran Sam Darnold after a breakout campaign ... But what if we told you the Pro Bowl passer's looming free agency isn't the team's most disputatious talking point?

Dis­ease-re­ver­sal start­up Retro Bio­sciences is aim­ing for a $1 bil­lion fund­ing round, a spokesper­son for the com­pa­ny con­firmed in a Fri­day email to End­points News … ...

Retro Biosciences Inc ... The Financial Times today cited sources as saying that OpenAI Chief Executive Sam Altman is participating in the investment. He previously provided the initial $180 ...

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through his support of Retro Biosciences, a San Francisco-based biotech startup. The ...

OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Altman ...